Loading clinical trials...
Loading clinical trials...
Predictive Factors of Graft Detachment Following Dmek: Retrospective Study About 170 Cases
The aim of this study was to identify the predictive factors of graft detachment after Descemet Membrane Endothelial Keratoplasty (DMEK) surgery. This retrospective study was conducted on patients aged 18 years, with Fuchs' dystrophy (FECD) or pseudophakic bullous keratopathy (PBK), who were scheduled for DMEK or triple-DMEK (combined phacoemulsification and DMEK surgery). Patients with a history of surgery other than cataract surgery were excluded. The study was conducted between 2014 and 2022 and follow-up was for 3 months. The characteristics of patients with and without graft detachment following surgery were compared using logistic regression.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
CHR Metz-Thionville/Hopital de Mercy
Metz, France
Start Date
March 1, 2022
Primary Completion Date
June 1, 2022
Completion Date
June 1, 2022
Last Updated
September 8, 2022
170
ACTUAL participants
Descemet Membrane Endothelial Keratoplasty
PROCEDURE
Lead Sponsor
Centre Hospitalier Régional Metz-Thionville
NCT05436665
NCT06881771
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions